Pitfalls in hemoglobin A1c measurement: when results may be misleading.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24002631.
- Also identified by DOI 10.1007/s11606-013-2595-x and PMC identifier 3912281.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Since the beginning of clinical use in the 1970s, hemoglobin A1c (A1c) has become the standard tool for monitoring glycemic control in patients with diabetes. The role of the A1c test was broadened in 2010, when the American Diabetes Association added A1c as a diagnostic criterion for diabetes. Because of hemoglobin A1c's integral role in diagnosis and treatment, it is important to recognize clinical scenarios and interfering factors that yield false results. The purpose of this review is to describe the A1c measurement, outline clinical scenarios or factors that may yield false results, and describe alternative laboratory biomarkers.
Medical subject headings
- Blood Glucose
- Diabetes Mellitus, Type 2
- Glycated Hemoglobin